SINGULEX

singulex-logo

Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand and manage disease. The company develops biomarker diagnostic systems that can detect and quantify normal and abnormal protein biomarkers. It is conducting pilot studies to validate Erenna BioAssay System, a digital molecule detection platform, which detects and quantifies molecule biomarkers in clinical s... amples. The company also offers various custom assay services, such as pilot study services, assay prototyping, assay characterization, and assay validation. The company was formerly known as BioProfile Corporation and changed its name to Singulex, Inc in September 2003. Singulex is based in Hayward, California

#SimilarOrganizations #People #Financial #Website #More

SINGULEX

Social Links:

Industry:
Biotechnology Health Care Life Science Medical

Founded:
2003-01-01

Address:
Alameda, California, United States

Country:
United States

Website Url:
http://www.singulex.com

Total Employee:
101+

Status:
Active

Contact:
5108149021

Email Addresses:
[email protected]

Total Funding:
227.34 M USD

Technology used in webpage:
SPF Domain Not Resolving Mobile Non Scaleable Content Euro ReCAPTCHA JQuery CDN ReCAPTCHA V2 Smart App Banner Google No Translate Contabo


Similar Organizations

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

richard-popp_image

Richard Popp Chair & Medical Advisory Board @ Singulex
Board_member
2010-12-01

not_available_image

Stephen L. Rose Board of Directors @ Singulex
Board_member
2004-01-01

rdouglas-norby_image

R.Douglas Norby Board of Directors @ Singulex
Board_member
2012-01-01

heiner-dreismann_image

Heiner Dreismann Board of Directors @ Singulex
Board_member

carl-l-gordon_image

Carl L. Gordon Board of Directors @ Singulex
Board_member
2007-01-01

andre-marion_image

Andre Marion Board of Directors @ Singulex
Board_member
2006-01-01

Current Employees Featured

not_available_image

F. Steven Feinberg
F. Steven Feinberg Senior Vice President of Sales and Marketing and Chief Commercial Officer @ Singulex
Senior Vice President of Sales and Marketing and Chief Commercial Officer

not_available_image

William Hammack
William Hammack Vice President Human Resources @ Singulex
Vice President Human Resources
2009-11-01

Founder


guido-baechler_image

Guido Baechler

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Debt Financing - Singulex

grifols_image

Grifols

Grifols investment in Funding Round - Singulex

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - Singulex

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Debt Financing - Singulex

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series G - Singulex

jafco-asia_image

JAFCO Asia

JAFCO Asia investment in Series G - Singulex

prolog-ventures_image

Prolog Ventures

Prolog Ventures investment in Series G - Singulex

fisk-ventures_image

Fisk Ventures

Fisk Ventures investment in Series G - Singulex

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series F - Singulex

fisk-ventures_image

Fisk Ventures

Fisk Ventures investment in Series F - Singulex

Official Site Inspections

http://www.singulex.com Semrush global rank: 5.68 M Semrush visits lastest month: 1.48 K

  • Host name: 245.106.252.198.static.reverse.arandomserver.com
  • IP address: 198.252.106.245
  • Location: Los Angeles United States
  • Latitude: 34.0549
  • Longitude: -118.2578
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90014

Loading ...

More informations about "Singulex"

Who We Are - Singulex

Singulex is a leader in single molecule counting technology for clinical diagnostics and scientific discovery.See details»

Leadership - Singulex

Byron Clendenen joined Singulex in 2014 and possesses 25 years of HR leadership experience. Previously, Byron served and led HR functions in diverse settings such as CollabNet, Inc., …See details»

Singulex - About Singulex

Singulex, Inc. has pioneered single-molecule counting technology that can quantitatively measure single molecules such as proteins and metabolites directly in complex biological samples …See details»

Singulex Company Profile 2024: Valuation, Funding & Investors

Singulex General Information Description. Manufacturer and developer of single molecule counting technology equipment designed to help clinicians distinguish healthy patients from …See details»

Singulex Company Profile - Office Locations, Competitors ... - Craft

Singulex, Inc., a biotechnology company, develops and commercializes direct molecular detection technology solutions. Its solutions enable life science researchers and clinicians to understand …See details»

Singulex Inc - Company Profile and News - Bloomberg Markets

Company profile page for Singulex Inc including stock price, company news, executives, board members, and contact informationSee details»

SINGULEX, INC. Company Profile | Saint Louis, MO | Competitors ...

Singulex, inc. d&b business directory home / business directory / professional, scientific, and technical services / other professional, scientific, and technical services / united states / …See details»

Singulex - Contacts, Employees, Board Members, Advisors & Alumni

Organization. Singulex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor Profiles 6. …See details»

Meet the Singulex Executive Management and Leadership Team

Prior to joining Singulex, ... During this time, Jeff held various scientific and leadership positions within the R&D organization including Vice President of R&D for Point of Care platforms and …See details»

Singulex - Funding, Financials, Valuation & Investors - Crunchbase

Singulex is funded by 11 investors. Perceptive Advisors and Grifols are the most recent investors. Singulex has a post-money valuation in the range of $100M to $500M as of Mar 15, 2012, …See details»

Immunodiagnostics Firm Singulex Shutters Abruptly - 360Dx

Jun 27, 2019 The Singulex Sgx Clarity system, which was CE-marked in 2017, also uses the SMC technology. Singulex launched a CE-marked troponin assay on Clarity in 2017 that was …See details»

SINGULEX | Drug Discovery News

Organization profile for SINGULEX on Drug Discovery News. Emerging gene editing approaches pave the way for safer, more successful transplants.See details»

Merck Millipore Acquire Exclusive Rights to Singulex Single …

Jun 25, 2015 Under the terms of the agreement, Merck Millipore will pay Singulex an upfront payment, royalties and additional payments based upon achievement of certain commercial …See details»

Singulex - Executive Management

Jeff Bishop joined Singulex in September 2013 as our Vice President of Research and Development. Dr. Bishop has worked in the diagnostic industry for over 13 years, including …See details»

Working At Singulex: Company Overview and Culture - Zippia

Mar 14, 2024 Singulex has 50 employees. 49% of Singulex employees are women, while 51% are men. The most common ethnicity at Singulex is White (39%). 24% of Singulex employees …See details»

Molecular Dx company Singulex nabs $50M deal with Grifols for …

May 31, 2016 Molecular diagnostics company Singulex has gained a $50 million investment from Grifols in exchange for a 20% stake. The deal provides an exclusive worldwide license of …See details»

About Singulex - Revolutionizing Molecular Research - Singulex

Singulex currently is developing the Singulex Clinical Diagnostic System, a fully-automated in vitro diagnostics system that will bring the benefits of its SMC technology to hospital and reference …See details»

Singulex Readies Immunodiagnostics System for CE Mark …

May 25, 2016 NEW YORK (GenomeWeb) – Singulex has shipped its first Singulex Clarity system — an immunodiagnostics platform based on single-molecule counting technology — to …See details»

Investors – Singulex

Fisk Ventures LLC is a private venture capital fund of H. Fisk Johnson, Ph.D., Chairman of the Board, the Chairman and Chief Executive Officer of S.C. Johnson & Son, Inc. Grifols is a …See details»

linkstock.net © 2022. All rights reserved